INSPIRE MEDICAL SYSTEMS INC INSP
ASignal's systematic analysis rates INSP as Neutral.
Reflects the latest available analysis · analyzed Oct 13, 2026
The case on INSP
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong financial health with low debt-to-equity ratio (0.04x)
- High gross margin (86.13%) indicating pricing power
- Return on equity above threshold at 17.97%
- Current ratio (8.55x) and quick ratio (5.96x) reflect exceptional liquidity
- Free cash flow positive at $94.64M
- Negative revenue growth (YoY: -7.60%)
- Negative operating margin (-0.26%) despite high gross margin
- MACD below signal line with negative histogram, indicating weakening momentum
- Price momentum slightly negative
- Forward P/E elevated at 46.27x despite current P/E of 15.75x
See the full verdict on INSP
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes INSP
Most investors never get a second opinion, let alone several. ASignal runs INSP past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.